Voriconazole and posaconazole therapeutic drug monitoring: a retrospective study
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Voriconazole and posaconazole therapeutic drug monitoring: a retrospective study
Authors
Keywords
Voriconazole, Posaconazole, Therapeutic drug monitoring, Invasive fungal disease
Journal
Annals of Clinical Microbiology and Antimicrobials
Volume 16, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-09-11
DOI
10.1186/s12941-017-0235-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pharmacokinetics of Posaconazole Suspension in Lung Transplant Patients with and without Cystic Fibrosis
- (2016) Hongfei Zhang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
- (2016) Thomas F. Patterson et al. CLINICAL INFECTIOUS DISEASES
- Impact of CYP2C19 genetic polymorphisms on voriconazole dosing and exposure in adult patients with invasive fungal infections
- (2016) Fabien Lamoureux et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Effectiveness of increasing the frequency of posaconazole syrup administration to achieve optimal plasma concentrations in patients with haematological malignancy
- (2016) Wan Beom Park et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Utility of voriconazole therapeutic drug monitoring: a meta-analysis
- (2016) Me-Linh Luong et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Therapeutic drug monitoring of voriconazole in Japanese patients: analysis based on clinical practice data
- (2016) Kazuaki Matsumoto et al. JOURNAL OF CHEMOTHERAPY
- Therapeutic drug monitoring of voriconazole helps to decrease the percentage of patients with off-target trough serum levels
- (2016) Jesús Guinea et al. MEDICAL MYCOLOGY
- Comparison of posaconazole serum concentrations from haematological cancer patients on posaconazole tablet and oral suspension for treatment and prevention of invasive fungal infections
- (2016) Aaron N. Pham et al. MYCOSES
- Voriconazole Therapeutic Drug Monitoring Practices in Intensive Care
- (2016) Marjolijn J. P. van Wanrooy et al. THERAPEUTIC DRUG MONITORING
- Superior Serum Concentrations with Posaconazole Delayed-Release Tablets Compared to Suspension Formulation in Hematological Malignancies
- (2015) Aaron Cumpston et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Determination of posaconazole concentration with LC–MS/MS in adult patients with hematologic malignancy
- (2015) Hyojin Chae et al. CLINICA CHIMICA ACTA
- Clinical usefulness of therapeutic drug monitoring of voriconazole in a university hospital
- (2015) Evelyn Cabral-Galeano et al. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
- Serum posaconazole levels among haematological cancer patients taking extended release tablets is affected by body weight and diarrhoea: single centre retrospective analysis
- (2015) Marisa H. Miceli et al. MYCOSES
- Pharmacokinetic and Pharmacodynamic Properties of Oral Voriconazole in Patients with Invasive Fungal Infections
- (2015) Taotao Wang et al. PHARMACOTHERAPY
- Subtherapeutic Posaconazole Exposure and Treatment Outcome in Patients With Invasive Fungal Disease
- (2015) Kim C. M. van der Elst et al. THERAPEUTIC DRUG MONITORING
- Therapeutic Drug Monitoring and Dose Adjustment of Posaconazole Oral Suspension in Adults With Acute Myeloid Leukemia
- (2015) Shelly E. Hummert et al. THERAPEUTIC DRUG MONITORING
- Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy, 2014
- (2014) M. M. Chau et al. INTERNAL MEDICINE JOURNAL
- Impact of structured personal on-site patient education on low posaconazole plasma concentrations in patients with haematological malignancies
- (2014) Martin Hoenigl et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- A Reference Laboratory Experience of Clinically Achievable Voriconazole, Posaconazole, and Itraconazole Concentrations within the Bloodstream and Cerebral Spinal Fluid
- (2013) Nathan P. Wiederhold et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Voriconazole therapeutic drug monitoring: retrospective cohort study of the relationship to clinical outcomes and adverse events
- (2013) Helen Y Chu et al. BMC INFECTIOUS DISEASES
- Optimizing antifungal choice and administration
- (2013) David Andes CURRENT MEDICAL RESEARCH AND OPINION
- Posaconazole Therapeutic Drug Monitoring in the Real-life Setting: A Single-Center Experience and Review of the Literature
- (2013) Barbara N. Gross et al. PHARMACOTHERAPY
- Multicenter Study of Posaconazole Therapeutic Drug Monitoring: Exposure-Response Relationship and Factors Affecting Concentration
- (2012) Michael J. Dolton et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Prospective, Observational Study of Voriconazole Therapeutic Drug Monitoring among Lung Transplant Recipients Receiving Prophylaxis: Factors Impacting Levels of and Associations between Serum Troughs, Efficacy, and Toxicity
- (2012) Dimitra Mitsani et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multicenter Study of Voriconazole Pharmacokinetics and Therapeutic Drug Monitoring
- (2012) Michael J. Dolton et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Effect of Therapeutic Drug Monitoring on Safety and Efficacy of Voriconazole in Invasive Fungal Infections: A Randomized Controlled Trial
- (2012) Wan Beom Park et al. CLINICAL INFECTIOUS DISEASES
- Factors influencing the pharmacokinetics of prophylactic posaconazole oral suspension in patients with acute myeloid leukemia or myelodysplastic syndrome
- (2012) J. J. Vehreschild et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Antifungal Prophylaxis in Lung Transplantation-A World-wide Survey
- (2011) C. F. Neoh et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Observational Study of the Clinical Efficacy of Voriconazole and Its Relationship to Plasma Concentrations in Patients
- (2011) Peter F. Troke et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A post-marketing evaluation of posaconazole plasma concentrations in neutropenic patients with haematological malignancy receiving posaconazole prophylaxis
- (2011) Alexander M. Bryant et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Voriconazole drug monitoring in the management of invasive fungal infection in immunocompromised children: a prospective study
- (2011) P. Soler-Palacin et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Posaconazole Plasma Concentrations in Critically Ill Patients
- (2011) John Ray et al. THERAPEUTIC DRUG MONITORING
- A 35-Year Longitudinal Assessment of Cognition and Midlife Depression Symptoms: The Vietnam Era Twin Study of Aging
- (2010) Carol E. Franz et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- Exposure–Response of Posaconazole Used for Prophylaxis Against Invasive Fungal Infections: Evaluating the Need to Adjust Doses Based on Drug Concentrations in Plasma
- (2010) S H Jang et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Clinician Ordering Practices for Voriconazole Therapeutic Drug Monitoring: Experiences of a Referral Laboratory
- (2010) Spiros Miyakis et al. THERAPEUTIC DRUG MONITORING
- Therapeutic Drug Monitoring of Posaconazole: a Monocentric Study with 54 Adults
- (2009) D. Lebeaux et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Voriconazole Pharmacokinetics and Pharmacodynamics in Children
- (2009) Michael Neely et al. CLINICAL INFECTIOUS DISEASES
- Voriconazole concentrations and outcome of invasive fungal infections
- (2009) S. Miyakis et al. CLINICAL MICROBIOLOGY AND INFECTION
- Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
- (2008) Ben De Pauw et al. CLINICAL INFECTIOUS DISEASES
- Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes
- (2007) A. Pascual et al. CLINICAL INFECTIOUS DISEASES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now